Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Semtech Corporation Common Stock (SMTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Semtech Corporation Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5 (market cap $1.74B), while Semtech Corporation Common Stock trades at $187.3 (market cap $17.49B). The key difference: Semtech Corporation Common Stock is far larger — about 10.1× Nuvation Bio Inc. Class A Common Stock's market cap, and Semtech Corporation Common Stock is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Semtech Corporation Common Stock for 1 Days on average.
| NUVB | SMTC | |
|---|---|---|
Market Cap | $1.74B | $17.49B |
Volume | 9,289,619 | 4,235,937 |
Sector | Health | Technology |
52-Week High | $9.54 | $197.20 |
52-Week Low | $3.41 | $62.57 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $1.33B | $17.78B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Semtech Corporation Common Stock
Semtech develops analog and mixed-signal semiconductors and connectivity products. Its technologies are used in communications, data centers, industrial systems, and IoT devices.
Read more on SMTC →
